Alcohol Abuse Clinical Trial
— CaesarOfficial title:
Benefit of Carbohydrate Deficient Transferrin to Detect Chronic Alcohol Abuse in the Elderly. A French Multicentered Prospective Interventional Study.
Alcohol misuse affects 5 million people in France. Even though the elderly are also
concerned by this pathology, there is not much information about chronic alcohol misuse of
this population in particular.
Biological markers like gamma-glutamyltranspeptidase (GGT), mean corpuscular volume (MCV)
and carbohydrate deficient transferrin (CDT) are usually used to detect alcohol abuse. As a
biological marker of alcohol misuse, the specificity of the CDT is known to be superior to
the GGT as well.
However, when it comes to the elderly, alcoholism diagnosis tools are based on research of
younger populations.
This study aims to evaluate the benefit of the CDT to detect chronic alcohol use in the
elderly.
Status | Completed |
Enrollment | 194 |
Est. completion date | October 2016 |
Est. primary completion date | October 2016 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 60 Years and older |
Eligibility |
Inclusion Criteria: - At least 60 years old - Patients hospitalized for a day or more in the Geriatrics Department of Mulhouse, GHRMSA : - Coming from home within 48 hours after admission to the GHRMSA - Study procedures performed within 72 hours after admission to the GHRMSA - Or new members of the General Practitioner Support Association of Alsace, France (translated in French as the "RAG") living in Mulhouse, Thann and Saint Louis cities (France) : - Living at home and joining the RAG between the 1st of March and the 31st of October 2016 - Study Procedures performed within 3 days after enrollment in the study - Relative or helper available who usually visits the patient at home at least once a week - Absence of alcoholic excipient in the concomitant medication Exclusion Criteria: - Age < 60 years old - Admitted in the Geriatrics Department of Mulhouse after more than 48hours after admission to the GHRMSA - Presence of the following symptoms : - Hepatobiliary deficiency related to a primary biliary cirrhosis - Autoimmune or viral cirrhosis - Hepatocellular carcinoma - Congenital metabolic disorder in protein glycosylation - Known genetics variance in Tf B or D transferrin - Living in an elderly care institution - Already enrolled in this study |
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Country | Name | City | State |
---|---|---|---|
France | Reseau d'Appui aux Generalistes (RAG) | Colmar | |
France | GHRMSA | Mulhouse |
Lead Sponsor | Collaborator |
---|---|
Groupe Hospitalier de la Region de Mulhouse et Sud Alsace |
France,
Allen JP, Litten RZ, Anton RF, Cross GM. Carbohydrate-deficient transferrin as a measure of immoderate drinking: remaining issues. Alcohol Clin Exp Res. 1994 Aug;18(4):799-812. Review. — View Citation
Anton RF, Lieber C, Tabakoff B; CDTect Study Group.. Carbohydrate-deficient transferrin and gamma-glutamyltransferase for the detection and monitoring of alcohol use: results from a multisite study. Alcohol Clin Exp Res. 2002 Aug;26(8):1215-22. — View Citation
Bortolotti F, De Paoli G, Tagliaro F. Carbohydrate-deficient transferrin (CDT) as a marker of alcohol abuse: a critical review of the literature 2001-2005. J Chromatogr B Analyt Technol Biomed Life Sci. 2006 Sep 1;841(1-2):96-109. Review. — View Citation
Henni A, Bideau C, Routon X, Berrut G, Cholet J. [Prevalence and issues of screening for alcohol consumption among elderly inpatients admitted to acute geriatric inpatient unit]. Geriatr Psychol Neuropsychiatr Vieil. 2013 Mar;11(1):33-41. doi: 10.1684/pnv.2013.0397. French. — View Citation
Hermansson U, Helander A, Huss A, Brandt L, Rönnberg S. The Alcohol Use Disorders Identification Test (AUDIT) and carbohydrate-deficient transferrin (CDT) in a routine workplace health examination. Alcohol Clin Exp Res. 2000 Feb;24(2):180-7. — View Citation
Mundle G, Ackermann K, Munkes J, Steinle D, Mann K. Influence of age, alcohol consumption and abstinence on the sensitivity of carbohydrate-deficient transferrin, gamma-glutamyltransferase and mean corpuscular volume. Alcohol Alcohol. 1999 Sep-Oct;34(5):760-6. — View Citation
Salaspuro M. Carbohydrate-deficient transferrin as compared to other markers of alcoholism: a systematic review. Alcohol. 1999 Nov;19(3):261-71. Review. — View Citation
Schwan R, Albuisson E, Malet L, Loiseaux MN, Reynaud M, Schellenberg F, Brousse G, Llorca PM. The use of biological laboratory markers in the diagnosis of alcohol misuse: an evidence-based approach. Drug Alcohol Depend. 2004 Jun 11;74(3):273-9. — View Citation
WHO Expert Committee on Problems Related to Alcohol Consumption.. WHO Expert Committee on Problems Related to Alcohol Consumption. Second report. World Health Organ Tech Rep Ser. 2007;(944):1-53, 55-7, back cover. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Benefit of Carbohydrate Deficient Transferrin to detect chronic alcohol abuse in the elderly compared to usual clinical detection tools | Analysis performed when at least 1 point at the AUDIT-C questionnaire, confirming presence of alcohol consumption | Within 3 days after enrollment in the study | No |
Secondary | Sensitivity and specificity of the disturbance of Gamma-glutamyltranspeptidase when presence of alcohol consumption, with at least 1 point in the AUDIT-C questionnaire | If collected as routine practice : at the same time as Carbohydrate Deficient Transferrin analysis when Audit-C questionnaire reports at least 1 point | Within 3 days after enrollment in the study | No |
Secondary | Sensitivity and specificity of the disturbance of Mean Corpuscular Volume when presence of alcohol consumption, with at least 1 point in the AUDIT-C questionnaire | If collected as routine practice : at the same time as Carbohydrate Deficient Transferrin analysis when Audit-C questionnaire reports at least 1 point | Within 3 days after enrollment in the study | No |
Secondary | Socio-economic characteristics of alcohol abusers : Socioprofessional category | Classification of professions and socioprofessional categories of the French National institute of Statistics and economics. 9 types of working classes. | Within 3 days after enrollment in the study | No |
Secondary | Socio-economic characteristics of alcohol abusers : Education Category | 6 levels of education type, from no degree or 9th grade, to Doctor of Philosophy (PhD). Classification created by the French National institute of Statistics and economics | Within 3 days after enrollment in the study | No |
Secondary | Socio-economic characteristics of alcohol abusers : Way of life | Description of the patient's environment : married or not living alone or not professional help provided at home by either a nurse, or cleaning lady, or meal delivery, or senior helper |
Within 3 days after enrollment in the study | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03165942 -
Neuroendocrine Response to Oral Alcohol Administration
|
Phase 1 | |
Recruiting |
NCT05343039 -
Technology Enhanced Adolescent Mental Health (TEAM)
|
N/A | |
Active, not recruiting |
NCT04070521 -
EEG Monitoring in the Emergency Department
|
||
Completed |
NCT03169244 -
Buproprion for Binge Drinking
|
Phase 2 | |
Recruiting |
NCT05246202 -
Personalized Feedback Intervention for Latinx Drinkers With Anxiety
|
N/A | |
Completed |
NCT05036499 -
PFI for Pain-Related Anxiety Among Hazardous Drinkers With Chronic Pain
|
N/A | |
Recruiting |
NCT04368416 -
Anxiety/Depression, Sleep and Alcohol in Elderly Anxiety/Depression, Sleep Disturbances and Alcohol Use Disorder in Elderly With Cognitive Complaints
|
||
Not yet recruiting |
NCT04557631 -
Evaluation of the Threshold for the Interpretation of the Results of a Method for the Blood Determination of Phosphatidyléthanol
|
||
Terminated |
NCT00890149 -
Ondansetron for the Treatment of Heavy Drinking Among Emerging Adults
|
Phase 2 | |
Completed |
NCT02179749 -
Mifepristone Treatment of Alcohol Use Disorder
|
Phase 2 | |
Completed |
NCT02681406 -
Smartphone Based Continuing Care for Alcohol
|
N/A | |
Completed |
NCT02448134 -
A Community-Based Strategy for Preventing Underage Drinking
|
N/A | |
Withdrawn |
NCT01847300 -
cSBI-M for Young Military Personnel
|
N/A | |
Withdrawn |
NCT01796158 -
Pilot Test of Computerized MET to Reduce Adolescent Alcohol Use
|
N/A | |
Terminated |
NCT01408641 -
Topiramate for Alcohol Use in Posttraumatic Stress Disorder
|
N/A | |
Withdrawn |
NCT01511679 -
Brain-imaging and Adolescent Neuroscience Consortium
|
N/A | |
Completed |
NCT01553136 -
Varenicline Treatment of Alcohol Dependence in Smokers
|
Phase 2 | |
Withdrawn |
NCT01275391 -
cSBIRT to Reduce Teen Tobacco, Alcohol and Drug Use
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT01539525 -
Screening to Augment Referral to Treatment- Project START
|
Phase 2 | |
Completed |
NCT01207258 -
Brief Intervention for Problem Drinking and Partner Violence
|
Phase 2 |